The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: A systematic review

European Journal of Endocrinology

Volumn 169, Issue 6, 2013, Pages 853-865

  Krul Poel, Y H M ^a   Snackey, C ^a   Louwers, Y ^b   Lips, P ^c   Lambalk, C B ^d   Laven, J S E ^b   Simsek, S ^a,c  

^a Location Alkmaar   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Department of Internal Medicine/Endocrinology ^*  (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ATORVASTATIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; METFORMIN; PLACEBO; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN; VITAMIN;

ARTICLE; BODY MASS; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; META ANALYSIS; METABOLIC DISORDER; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VDR GENE; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; GENETIC POLYMORPHISM; GENETICS; METABOLISM;

BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84888247332     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0617     Document Type: Article

References (56)

1. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 2012 97 28-38. (doi:10.1016/j. fertnstert.2011.09.024)
2. de Groot PC, Dekkers OM, Romijn JA, Dieben SW & Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reproduction Update 2011 17 495-500. (doi:10.1093/humupd/dmr001)
3. Diamanti-Kandarakis E & Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews 2012 33 981-1030. (doi:10.1210/er.2011-1034)
4. Wild RA, Rizzo M, Clifton S & Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertility and Sterility 2011 95 1073-1079. (doi:10.1016/j.fertnstert. 2010.12.027)
5. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK & Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999 22 141-146. (doi:10.2337/diacare.22.1.141)
6. Moran LJ, Misso ML, Wild RA & Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 2010 16 347-363. (doi:10.1093/humupd/dmq001)
7. Norman RJ, Dewailly D, Legro RS & Hickey TE. Polycystic ovary syndrome. Lancet 2007 370 685-697. (doi:10.1016/S0140-6736 (07) 61345-2)
8. Dunaif A, Segal KR, Futterweit W & Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 38 1165-1174. (doi:10.2337/diab.38.9.1165)
9. Ketel IJ, Serne EH, Ijzerman RG, Korsen TJ, Twisk JW, Hompes PG, Smulders YM, Homburg R, Vorstermans L, Stehouwer CD et al. Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS. Human Reproduction 2011 26 3130-3137. (doi:10.1093/humrep/der296)
10. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C & Demay M. VitaminD and human health: lessons from vitamin D receptor null mice. Endocrine Reviews 2008 29 726-776. (doi:10.1210/er.2008-0004)
11. Alvarez JA & Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. International Journal of Endocrinology 2010 2010 351385. (doi:10.1155/2010/351385)
12. Chiu KC, Chu A, Go VL & Saad MF. Hypovitaminosis D is associated with insulin resistance and b cell dysfunction. American Journal of Clinical Nutrition 2004 79 820-825.
13. Ford ES, Ajani UA, McGuire LC & Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U. S. adults. Diabetes Care 2005 28 1228-1230. (doi:10.2337/diacare.28.5.1228)
14. Pittas AG, Lau J, Hu FB & Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. Journal of Clinical Endocrinology and Metabolism 2007 92 2017-2029. (doi:10.1210/jc.2007- 0298)
15. Scragg R, Sowers M & Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 27 2813-2818. (doi:10.2337/diacare.27.12.2813)
16. Thomson RL, Spedding S & Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical Endocrinology 2012 77 343-350. (doi:10.1111/j.1365-2265.2012. 04434.x)
17. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47. (doi:10.1093/humrep/deh098)
18. Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K & Janssen OE. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Experimental and Clinical Endocrinology & Diabetes 2006 114 577-583. (doi:10.1055/s-2006-948308)
19. Li HW, Brereton RE, Anderson RA, Wallace AM & Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011 60 1475-1481. (doi:10.1016/j. metabol.2011.03.002)
20. Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS & Ezabadi Z. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertility and Sterility 2010 93 1208-1214. (doi:10.1016/j.fertnstert.2008.11.031)
21. Muscogiuri G, Policola C, Prioletta A, Sorice G, Mezza T, Lassandro A, Della CS, Pontecorvi A & Giaccari A. Low levels of 25 (OH) D and insulin-resistance: 2 unrelated features or a causeeffect in PCOS? Clinical Nutrition 2012 31 476-480. (doi:10.1016/j.clnu.2011.12.010)
22. Ngo DT, Chan WP, Rajendran S, Heresztyn T, Amarasekera A, Sverdlov AL, O'Loughlin PD, Morris HA, Chirkov YY, Norman RJ et al. Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 2011 25 326-330. (doi:10.1016/j.niox.2011.06. 005)
23. Panidis D, Balaris C, Farmakiotis D, Rousso D, Kourtis A, Balaris V, Katsikis I, Zournatzi V & Diamanti-Kandarakis E. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clinical Chemistry 2005 51 1691-1697. (doi:10.1373/clinchem.2005.052761)
24. Savastano S, Valentino R, Di Somma C, Orio F, Pivonello C, Passaretti F, Brancato V, Formisano P, Colao A, Beguinot F et al. Serum 25-hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS. Nutrition and Metabolism 2011 8 84. (doi:10.1186/1743-7075-8-84)
25. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR & Obermayer-Pietsch B. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. European Journal of Endocrinology 2009 161 575-582. (doi:10.1530/EJE-09-0432)
26. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG & Kamaci M. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of Gynecology and Obstetrics 2009 280 559-563. (doi:10.1007/s00404-009-0958-7)
27. Hassan NE, El Orabi HA, Eid YM & Mohammed NR. Effect of 25-hydroxyvitamin D on metabolic parameters and insulin resistance in patients with polycystic ovarian syndrome. Middle East Fertility Society Journal 2012 17 176-180. (doi:10.1016/j. mefs.2012.04.005)
28. Mazloomi S, Sharifi F, Hajihosseini R, Kalantari S & Mazloomzadeh S. Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinology 2012 2012 949427. (doi:10.5402/2012/949427)
29. Patra SK, Nasrat H, Goswami B & Jain A. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes & Metabolic Syndrome 2012 6 146-149. (doi:10.1016/j.dsx.2012. 09.006)
30. Ardabili HR, Gargari BP & Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutrition Research 2012 32 195-201. (doi:10.1016/j.nutres.2012.02. 001)
31. Firouzabadi R, Aflatoonian A, Modarresi S, Sekhavat L & Mohammad Taheri S. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complementary Therapies in Clinical Practice 2012 18 85-88. (doi:10.1016/j.ctcp. 2012.01.005)
32. Kotsa K, Yavropoulou MP, Anastasiou O & Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertility and Sterility 2009 92 1053-1058. (doi:10.1016/j.fertnstert.2008.07.1757)
33. Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J & Taylor H. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecological Endocrinology 2012 28 965-968. (doi:10.3109/09513590.2012. 696753)
34. Rahimi-Ardabili H, Pourghassem GB & Farzadi L. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. Journal of Endocrinological Investigation 2013 36 28-32. (doi:10.3275/8303)
35. Rashidi B, Haghollahi F, Shariat M & Zayerii F. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwanese Journal of Obstetrics & Gynecology 2009 48 142-147. (doi:10.1016/S1028-4559 (09) 60275-8)
36. Sathyapalan T, Shepherd J, Arnett C, Coady AM, Kilpatrick ES & Atkin SL. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clinical Chemistry 2010 56 1696-1700. (doi:10.1373/clinchem.2010. 144014)
37. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E & Imamoglu S. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. Journal of Endocrinological Investigation 2010 33 234-238. (doi:10.3275/6560)
38. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P & Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999 64 430-435. (doi:10.1016/S0039-128X (99) 00012-4)
39. Wehr E, Pieber TR & Obermayer-Pietsch B. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. Journal of Endocrinological Investigation 2011 34 757-763. (doi:10.3275/7748)
40. Bonakdaran S, Khorasani ZM, Davachi B & Khorasani JM. The effects of calcitriol on improvement of insulin resistance, ovulation and comparison with metformin therapy in PCOS patients: a randomized placebo-controlled clinical trial. Iranian Journal of Reproductive Medicine 2012 10 465-472.
41. Lin MW, Tsai SJ, Chou PY, Huang MF, Sun HS & Wu MH. Vitamin D receptor 1a promoter K1521 G/C and K1012 A/G polymorphisms in polycystic ovary syndrome. Taiwanese Journal of Obstetrics & Gynecology 2012 51 565-571. (doi:10.1016/j.tjog. 2012.09.011)
42. Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertility and Sterility 2009 92 1381-1383. (doi:10.1016/j.fertnstert.2009.05.002)
43. Ranjzad F, Mahban A, Shemirani AI, Mahmoudi T, Vahedi M, Nikzamir A & Zali MR. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics 2011 28 225-232. (doi:10.1007/s10815-010- 9506-4)
44. Ranjzad F, Mahmoudi T, Irani SA, Mahban A, Nikzamir A, Vahedi M, Ashrafi M & Gourabi H. A common variant in the adiponectin gene and polycystic ovary syndrome risk. Molecular Biology Reports 2012 39 2313-2319. (doi:10.1007/s11033-011-0981-1)
45. Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR & Obermayer-Pietsch B. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. European Journal of Endocrinology 2011 164 741-749. (doi:10.1530/EJE-11-0134)
46. Zadeh-Vakili A, Ramezani TF, Daneshpour MS, Zarkesh M, Saadat N & Azizi F. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene 2013 515 193-196. (doi:10.1016/j.gene.2012.11.049)
47. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P & Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clinical Chemistry 2012 58 531-542. (doi:10.1373/clinchem.2011.172155)
48. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC & Lips P. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. Journal of Clinical Endocrinology and Metabolism 2005 90 4119-4123. (doi:10.1210/jc.2005- 0216)
49. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P & Krassas GE. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. Journal of Clinical Endocrinology and Metabolism 2010 95 4251-4257. (doi:10.1210/jc.2010- 0757)
50. Salans LB, Knittle JL & Hirsch J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. Journal of Clinical Investigation 1968 47 153-165. (doi:10.1172/ JCI105705)
51. Dunaif A & Finegood DT. β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1996 81 942-947. (doi:10.1210/jc.81.3.942)
52. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800. (doi:10.1210/er.18.6.774)
53. Ketel IJ, Stehouwer CD, Serne EH, Korsen TJ, Hompes PG, Smulders YM, de Jongh RT, Homburg R & Lambalk CB. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 3365-3372. (doi:10.1210/jc.2008-0626)
54. Pittas AG, Harris SS, Stark PC & Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007 30 980-986. (doi:10.2337/dc06-1994)
55. Amer M & Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). American Journal of Cardiology 2012 109 226-230. (doi:10.1016/j.amjcard.2011.08.032)
56. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism 2011 96 53-58. (doi:10.1210/jc.2010-2704)